A genotype-controlled analysis of plasma dopamine β-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function

Biological Psychiatry

Volumn 52, Issue 12, 2002, Pages 1151-1158

  Köhnke, Michael D ^a   Zabetian, Cyrus P ^b,c   Anderson, George M ^d   Kolb, Werner ^e   Gaertner, Ines ^a   Buchkremer, Gerhard ^a   Vonthein, Reinhard ^a   Schick, Sandra ^a   Lutz, Ulrich ^a   Köhnke, Annette M ^a   Cubells, Joseph F ^b,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Wilhelmsheim Hospital   (Germany)

Author keywords

Alcoholism; HPLC; Norepinephrine; PCR; Polymorphism; Withdrawal

Indexed keywords

CLOMETHIAZOLE; DOPAMINE BETA MONOOXYGENASE;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLELE; ARTICLE; CONTROLLED STUDY; DELIRIUM TREMENS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL;

EID: 0037115116     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01427-0     Document Type: Article

References (50)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Press, Washington, DC.
2. Arango V., Underwood M.D., Mann J.J. Fewer pigmented neurons in the locus coeruleus of uncomplicated alcoholics. Brain Res. 650:1994;1-8.
3. Borg S., Kvande H., Mossberg D., Valverius P., Sedvall G. Central nervous system noradrenaline metabolism and alcohol consumption in man. Pharmacol Biochem Behav. 18:1983;1375-1378.
4. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
5. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology. 1986;Oxford University Press, New York.
6. Craig S.P., Buckle V.J., Lamouroux A., Mallet J., Craig I.W. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet. 48:1988;48-50.
7. Cubells J.F., Kobayashi K., Nagatsu T., Kidd K.K., Kidd J.R., Calafell F., et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet. 74:1997;374-379.
8. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., et al. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry. 5:2000;56-63.
9. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., et al. Dopamine beta-hydroxylase Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation . Hum Genet. 102:1998;533-540.
10. Cubells J.F., Price L.H., Meyers B.S., Anderson G.M., Zabetian C.P., Alexopoulos G.S., et al. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry. 51:2002;358-364.
11. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Nat Acad Sci USA. 98:2001;6917-6922.
12. Fahndrich E., Muller-Oerlinghausen B., Coper H. Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression. Int Pharmacopsychiatry. 17:1982;8-17.
13. Finckh U., Rommelspacher H., Kuhn S., Dufeu P., Otto G., Heinz A., et al. Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics. 7:1997;271-281.
14. Franke P., Schwab S.G., Knapp M., Gansicke M., Delmo C., Zill P., et al. DAT1 gene polymorphism in alcoholism A family-based association study . Biol Psychiatry. 45:1999;652-654.
15. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592.
16. Fujimoto A., Nagao T., Ebara T., Sato M., Otsuki S. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Biol Psychiatry. 18:1983;1141-1152.
17. Fulton M.K., Kramer G., Moeller F.G., Chae Y., Isbell P.G., Petty F. Low plasma homovanillic acid levels in recently abstinent alcoholic men. Am J Psychiatry. 152:1995;1819-1820.
18. Gelernter J., Kranzler H. D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects No association with phenotype or severity of phenotype . Neuropsychopharmacology. 20:1999;640-649.
19. Geracioti T.D., Loosen P.T., Ebert M.H., Ekhator N.N., Burns D., Nicholson W.E., Orth D.N. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients Serial sampling studies . Neuroendocrinology. 60:1994;635-642.
20. Goldin L.R., Gershon E.S., Lake C.R., Murphy D.L., McGinniss M., Sparkes R.S. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO) Possible linkage between the ABO locus and a gene controlling DBH activity . Am J Hum Genet. 34:1982;250-262.
21. Hawley R.J., Major L.F., Schulman E.A., Linnoila M. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal Correlations with clinical signs . Arch Gen Psychiatry. 42:1985;1056-1062.
22. Heinz A., Schmidt K., Baum S.S., Kuhn S., Dufeu P., Schmidt L.G., Rommelspacher H. Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. J Stud Alcohol. 57:1996;471-474.
23. Heinz A., Weingartner H., George D., Hommer D., Wolkowitz O.M., Linnoila M. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res. 89:1999;97-106.
24. Johansson A.K., Bergvall A.H., Hansen S. Behavioral disinhibition following basal forebrain excitotoxin lesions Alcohol consumption, defensive aggression, impulsivity and serotonin levels . Behav Brain Res. 102:1999;17-29.
25. Krystal J.H., Webb E., Cooney N.L., Kranzler H.R., Southwick S.W., Heninger G.R., Charney D.S. Serotonergic and noradrenergic dysregulation in alcoholism M-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects . Am J Psychiatry. 153:1996;83-92.
26. La Grange L., Jones T.D., Erb L., Reyes E. Alcohol consumption Biochemical and personality correlates in a college student population . Addict Behav. 20:1995;93-103.
27. Lykouras E., Moussas G., Markianos M. Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in non-abstinent chronic alcoholics Relation to clinical parameters . Drug Alcohol Depend. 19:1987;363-368.
28. McBride W.J., Bodart B., Lumeng L., Li T.K. Association between low contents of dopamine and serotonin in the nucleus accumbens and high alcohol preference. Alcohol Clin Exp Res. 19:1995;1420-1422.
29. Merikangas K.R. The genetic epidemiology of alcoholism. Psychol Med. 20:1990;11-22.
30. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
31. Nagaya T., Takahashi A., Yoshida I., Yokoyama M. Biphasic effects of smoking on human serum dopamine-beta-hydroxylase activity. Toxicol Lett. 60:1992;325-328.
32. Nestler E.J., Hope B.T., Widnell K.L. Drug addiction A model for the molecular basis of neural plasticity . Neuron. 11:1993;995-1006.
33. Peronnet F., Cleroux J., Perrault H., Thibault G., Cousineau D., de Champlain J., et al. Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man. Med Sci Sports Exerc. 17:1985;683-688.
34. Pickens R.W., Svikis D.S., McGue M., Lykken D.T., Heston L.L. Heterogeneity in the inheritance of alcoholism A study of male and female twins . Arch Gen Psychiatry. 48:1991;19-28.
35. Ross S.B., Wetterberg L., Myrhed M. Genetic control of plasma dopamine-beta-hydroxylase. Life Sci. 12:1973;529-532.
36. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry. 41:1997;299-304.
37. Sano H., Suzuki Y., Ohara K., Yazaki R., Ishigaki T., Yokoyama T., Ohara K. Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients. Alcohol Clin Exp Res. 16:1992;1047-1051.
38. Schuckit M.A., O'Connor D.T., Duby J., Vega R., Moss M. Dopamine-β-hydroxylase activity levels in men at high risk for alcoholism and controls. Biol Psychiatry. 16:1981;1067-1075.
39. Stanley W.C., Li B., Bonhaus D.W., Johnson L.G., Lee K., Porter S., et al. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol. 121:1997;1803-1809.
40. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) . Br J Addict. 84:1989;1353-1357.
41. Wei J., Ramchand C.N., Hemmings G.P. Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet. 99:1997;52-55.
42. Weinshenker D., Rust N.C., Miller N.S., Palmiter R.D. Ethanol-associated behaviors of mice lacking norepinephrine. J Neurosci. 20:2000;3157-3164.
43. Weinshilboum R.M. Serum dopamine-β-hydroxylase. Pharmacol Rev. 30:1978;133-166.
44. Weinshilboum R.M., Raymond F.A., Elveback L.R., Weidman W.H. Serum dopamine-beta-hydroxylase activity Sibling-sibling correlation . Science. 181:1973;943-945.
45. Weinshilboum R.M., Schorott H.G., Raymond F.A., Weidman W.H., Elveback L.R. Inheritance of very low serum dopamine-beta-hydroxylase activity. Am J Hum Genet. 27:1975;573-585.
46. Wilson A.F., Elston R.C., Sellers T.A., Bailey-Wilson J.E., Gersting J.M., Deen D.K., et al. Stepwise oligogenic segregation and linkage analysis illustrated with dopamine-beta-hydroxylase activity. Am J Med Genet. 35:1990;425-432.
47. Wilson A.F., Elston R.C., Siervogel R.M., Tran L.D. Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. Am J Hum Genet. 42:1988;160-166.
48. Winer N., Carter C. Effect of cold pressor stimulation on plasma norepinephrine, dopamine-β-hydroxylase, and renin activity. Life Sci. 20:1977;887-894.
49. Wittchen H.U., Zaudig M., Fydrich T. SKID. Strukturiertes Klinisches Interview fuer DSM-IV. 1997;Testzentrale, New York. (Users guide for the Structured Clinical Interview for DSM-IV, modified version, in German).
50. Zabetian C.P., Anderson G.A., Buxbaum S.G., Elston R.C., Ichinose H., Nagatsu T., et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity Evidence for a major functional polymorphism at the DBH locus . Am J Hum Genet. 68:2001;515-522.